Yonkers, New York Clinical Trials

A listing of Yonkers, New York clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 69 clinical trials
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer ALCHEMIST Chemo-IO Study

This phase III ALCHEMIST trial compares the addition of pembrolizumab to usual chemotherapy versus usual chemotherapy for the treatment of stage IB, II, or IIIA non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the …

carboplatin
stage iiia lung cancer ajcc v7
stage iiia lung squamous cell carcinoma ajcc v7
platelet count
monoclonal antibody therapy
Valley Health System-Hematology/Oncology
 (9.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +358 other locations
A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)

A phase 3 double blind, placebo controlled study evaluating the efficacy and safety of AL001 in participants at risk for or with frontotemporal dementia due to heterozygous mutations in the progranulin gene.

pick's disease
progranulin
aphasia
dementia
Irving Institute for Clinical and Translational Research
 (8.3 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +46 other locations
NA-831 Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection

This Phase 2/3 trial evaluates four treatment strategies for non-critically ill hospitalized participants (not requiring ICU admission and/or mechanical ventilation) with SARS CoV-2 infection, in which participants will receive NA-831 or Atazanavir with or without Dexamethasone.

dexamethasone
complete blood count
SARS
mechanical ventilation
g6pd
Coronavirus Research Institute-Testing Site-
 (5.1 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +29 other locations
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks and may include up to 4 visits.

treatment regimen
headache
ly573144
lasmiditan
preventive medication
Care Access Research - Bronx
 (8.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +162 other locations
2019-06 TRISCEND Study

Early feasibility study to assess safety and performance of the Edwards EVOQUE Tricuspid Valve Replacement System

tricuspid valve replacement
medical therapy
Columbia University Irving Medical Center / NYPH
 (8.3 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +6 other locations
CED of MTX110 Newly Diagnosed Diffuse Midline Gliomas

The blood brain barrier (BBB) prevents some drugs from successfully reaching the target source. Convection-Enhanced Delivery (CED) is a method of direct infusion of drugs under controlled pressure to the tumor that may reduce systemic side effects of drugs in the patient. The purpose of this Phase I study is …

platelet count
karnofsky performance status
seizures
anticonvulsants
pediatric
Columbia University Irving Medical Center
 (8.3 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
Tipifarnib for the Treatment of Advanced Solid Tumors Lymphoma or Histiocytic Disorders With HRAS Gene Alterations a Pediatric MATCH Treatment Trial

This phase II pediatric MATCH trial studies how well tipifarnib works in treating patients with solid tumors that have spread to other places in the body (advanced), lymphoma, or histiocytic disorders that have HRAS genetic alterations. Tipifarnib may block the growth of cancer cells that have specific genetic changes in …

radiopharmaceutical therapy
medulloblastoma
hematopoietic growth factors
radiopharmaceutical
platelet count
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
 (8.3 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +82 other locations
Double-Blind Multicenter Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19

This clinical trial will examine if a new treatment of Mesenchymal Stems Cells (called PLX-PAD) can help patients intubated and mechanically ventilated due to COVID-19 to recover more quickly with less complications.

SARS
acute respiratory distress
respiratory distress
covid-19
acute respiratory syndrome (sars)
Holy Medical Center
 (8.4 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +2 other locations
THE ALIGN-AR PIVOTAL TRIAL: JenaValve Pericardial TAVR Aortic Regurgitation Study

To collect information about treatment for symptomatic severe Aortic Regurgitation (AR), which affects the aortic valve in the heart. Aortic regurgitation is a condition where aortic valve in the heart does not close tightly and allows some blood to leak back into the heart chamber. Symptoms of aortic regurgitation may …

fatigue
shortness of breath
aortic valve replacement
regurgitation
New York-Presbyterian/ Columbia University Medical Center
 (8.3 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +9 other locations
Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI  

The objective of the proposed work is to determine whether administration for 12 months of romosozumab followed by 12 months of denosumab will maintain bone mass at the knee in subjects with subacute SCI compared to 24 months of denosumab administration alone.

James J. Peters VA Medical Center
 (5.6 away)
  • 0 views
  • 14 Mar, 2022
  • +1 other locations